Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

3 Pharma Stocks Smart Money Is Following in September

With the rising prevalence of chronic diseases, the demand for pharmaceutical products is anticipated to rise. Therefore, investors could consider buying three fundamentally robust pharma stocks, Eli Lilly and Company (LLY), Zoetis (ZTS), and Taro Pharmaceutical Industries (TARO), which are gaining traction among institutional investors this month. Learn more….

StockNews.com

Hundreds of women taking legal action against Bayer over Essure sterilisation device

The Essure device reportedly left many women suffering ‘excrutiating pain’ and other symptoms

Evening Standard

Insmed Is Making A Comeback — Why Shares Hit A Year High In Record Volume

Biotech stock Insmed rocketed Tuesday after the company said almost 44% of lung infection patients improved after receiving its drug.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Hundreds of women left in ‘excruciating pain’ from contraceptive coil launch legal action

‘I was in pain pretty much every day. And then I started having periods that lasted 28-30 days at a time,’ woman says

The Independent UK

Two hundred UK women can take legal action over Essure contraceptive device

Group claim able to proceed against maker Bayer after women said implant caused pain, BBC reports

The Guardian - UK

Wegovy maker Novo Nordisk becomes Europe’s most valuable firm

Launch of weight-loss drug in UK helps Danish firm to market value of $428bn

The Guardian - UK

3 Pharma Stocks for Value Investors

The aging global population and the growing demand for drugs and therapies to treat chronic diseases are boosting the long-term prospects of the pharmaceutical industry. Amid this backdrop, value investors could consider buying fundamentally strong pharma stocks GSK plc (GSK), Horizon Therapeutics (HZNP), and Neurocrine Biosciences (NBIX), as they are…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Top 3 Pharma Stocks to Boost Your Portfolio

As the global population ages and faces the increasing toll of chronic diseases, the pharmaceutical industry is expected to step up to meet people’s healthcare needs. Against this backdrop, pharma companies like Novo Nordisk (NVO), AbbVie (ABBV), and Novartis (NVS) could boost your portfolio. Read on….

StockNews.com

3 Pharma Stocks to Consider Prescribing to for Quality

The pharmaceutical industry is expected to thrive amid robust demand and technological advancements. Given the solid long-term prospects of the industry, investors should consider buying quality stocks, Johnson & Johnson (JNJ), AstraZeneca (AZN), and Dr. Reddy’s Laboratories (RDY). Read on.

StockNews.com

Medicines360’s long and winding, $82 million road to create and distribute $50 birth control

Drugs and medical devices rarely come from the nonprofit world

The Independent UK

3 Brilliant Biotech Stocks to Buy for Your Portfolio

The biotech industry is flourishing on the backs of positive clinical trials and new developments. Thus, it could be beneficial to add fundamentally robust biotech stocks BioMarin Pharmaceutical (BMRN), Equillium (EQ), and Organogenesis Holdings (ORGO) to your portfolios. Read more….

StockNews.com

Walgreens Boots shares lower as CEO Rosalind Brewer steps down

Walgreens Boots CEO Roz Brewer will leave the group just two and a half years after taking over from former chief Stefano Pessina.

The Street

About the new drug pricing negotiations

The first eligible drugs treat diabetes, blood clots, blood cancers, arthritis and heart disease

Salon

Ambrx Biopharma Has Surged 522% This Year. But It Could Just Be Getting Started.

Ambrx is no longer flying under the radar. Instead, AMAM stock has soared 522% this year as enthusiasm grows for its cancer smart bombs.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Chicago Sun-Times

5 things consumers need to know about Medicare’s new drug-pricing negotiations, how they’ll affect you

This could help people whose Medicare drug plans require big copayments. But the main relief will come from part of the Inflation Reduction Act that caps drug spending by Medicare recipients at $2,000 a year starting in 2025.

Kiplinger

Medicare Lists First 10 Drugs for Talks On Lowering Your Costs

New prices for Medicare Part D drugs on list expected in 2026.

StockNews.com

3 Best Biotech Stocks for Growth in 2023

The biotech industry is well-positioned for solid growth due to the growing demand for high-quality treatments for chronic diseases and an aging population. Therefore, it could be wise to invest in fundamentally strong biotech stocks Jazz Pharmaceuticals (JAZZ), Alkermes (ALKS), and Gilead Sciences (GILD), given their solid growth prospects. Read…

The Guardian - UK

Staffordshire-based Instem bought by private equity group for £203m

Instem is second UK life sciences company this week to be snapped up by a foreign buyer

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Biden touts Medicare negotiating drug prices: ‘Today is the start of a new deal for patients’

Announcement comes as Medicare names the drugs it will begin negotiations for prices

The Independent UK

3M agrees to multi-billion dollar settlement in earplug lawsuits from U.S. service members

Chemical and consumer product manufacturer 3M has agreed to pay $6 billion to settle numerous lawsuits from U.S. service members who say they experienced hearing loss or other serious injuries from using earplugs made by the company

StockNews.com

3 Best Biotech Stocks for Health and Wealth

With medical innovations and technological breakthroughs rapidly transforming the healthcare landscape, biotech stocks have garnered unprecedented attention in the investment community. Thus, fundamentally robust stocks like Incyte Corp. (INCY), Vertex Pharmaceuticals (VRTX), and Amgen (AMGN) could contribute to the health and wealth of your portfolios. Read more….

The Independent UK

What Biden’s announcement of Medicare negotiating drug prices means

Democrats have long wanted to allow Medicare to negotiate drug prices, which it hopes will lead to lower prescription costs

The Independent UK

3M agrees to pay $6 billion to settle earplug lawsuits from U.S. service members

WEKU

Here are the first 10 drugs that Medicare will target for price cuts

The government will negotiate new prices for the commonly prescribed drugs, but the cuts won't take effect until 2026. In the meantime, drugmakers are fighting the negotiations with lawsuits.

The Street

President Biden names first drugs targeted for Medicare price negotiation

In the biggest shakeup since Medicare was established in 1965, the Biden administration identified 10 prescription drugs it will target for direct price negotiations with producers.

1 … 26 27 28 29

People

Joe Biden

63,438 stories

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.